Delivery Order SPE2DB20D2104-SPE2DB25FMVKZ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,423.65 by the Defense Logistics Agency on September 8, 2025, for the supply of Orencia ClickJect 125 mg/mL. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,594.04 by the Defense Logistics Agency (DLA) for the supply of Orencia ClickJect 125 mg/mL on May 29, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of May 30, 2025 represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,752.32 for Orencia ClickJect 125 mg/ml on September 24, 2025. This non-competitive, firm fixed-price delivery order was funded through the Defense Logistics Agency's Medical Supply Chain and is set to be completed by September 25, 2025. The delivery will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $14,336.86 by the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of July 15, 2025. The order is for Orencia Clickjet 125 mg/mL, a specialty pharmaceutical product, under firm fixed price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,954.49 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $16,118.84, is classified as a non-set-aside contract and represents a competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 4, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This firm fixed-price delivery order, valued at $32,948.01 with an ultimate completion date of August 5, 2025, was issued with no set-aside designation and represents a competitively awarded contract. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,601.12 by the Defense Logistics Agency on July 11, 2025, for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in immunological and rheumatologic treatments. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and was awarded through open competition without set-aside designation. This award is a...
- The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,890.11 on June 16, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed-price delivery order, which is due for completion on June 17, 2025, was competitively awarded without set-aside designation to support the Medical Supply Chain, a division of the Defense Logistics Agency under the Department of Defense. The award represents a child contract under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVKZDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,944.57 by the Defense Logistics Agency on July 14, 2025, for the supply of Orencia ClickJet 125 mg/mL. The contract is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Orencia ClickJet, a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other autoimmune conditions, addresses the Defense Logistics Agency's pharmaceutical procurement needs for the military healthcare system. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 7/14/25 |